Health ingredients firm Acatris has developed a directly
compressible version of its SoyLife brand soy isoflavone
ingredient, designed to remove some of the hurdles for companies
looking to offer isoflavone capsules or tablets.
The UK government has given the national biotechnology industry
trade group £3 million (€4.3m) in funding to support the
development of bioprocessing, continuing a string of projects aimed
at boosting the UK biotech sector.
A new type of antidepressant drug with a novel mechanism of action,
which acts on a new target, has entered Phase I clinical trials.
The drug could represent a new generation of psycho-active
compounds that are devoid of the problems...
With safety a key issue amongst drug researchers and manufacturers,
Genaissance Pharmaceuticals has expanded its genetic testing
service, which can analyse key cardiac ion channel proteins
involved in drug-induced cardiac arrhythmias.
A new potential diabetes drug from Dia-B Tech, which is based on a
naturally occurring peptide consisting of four amino acids,
promises convenience and fewer side effects over current day
treatments for type 2 diabetes.
A unique three-way-deal between Dendritic Nanotechnologies (DNT),
The Dow Chemical Company and Starpharma Holdings, will provide DNT
and Starpharma with access to dendrimers and nanotechnology for
The use of chemical imaging as a quality control measure for
mixtures of pharmaceutical ingredients before tabletting has taken
a step forward with the first deployment of a prototype system at
Pfizer that is currently in the process...
Scientists have targeted the alkaloids of the quinolines chemical
family, which have proved effective against visceral leishmaniasis
treating this severe form of the disease with its antiparasitic